Many men get urinary problems as a side effect of their treatment. This is because prostate cancer treatment can damage the nerves and muscles that control when you urinate (pee).
If you’re starting treatment for prostate cancer, ask your doctor about the possible side effects. Each treatment can cause different urinary problems. Your chances of getting each side effect will depend on the treatment you’re having, and on whether or not you had urinary problems before starting treatment.
If you’ve already had prostate cancer treatment and you have urinary problems, tell your doctor or nurse. They can suggest treatments and lifestyle changes to help manage them.
This is the most common urinary problem after surgery. When you wake up after surgery, you’ll have a thin tube called a catheter in your penis. This is to drain urine out of your body. You'll usually have a catheter for about seven to 10 days after surgery. Most men can’t control their bladder properly when their catheter is first removed. This is because surgery can damage the muscles and nerves that control when you urinate.
Your hospital may give you some absorbent incontinence pads to put in your underwear. But you might want to take some pads with you when you go to have your catheter removed. Close fitting underwear can help to keep the pads in place, and men often find loose, lightweight trousers most comfortable.
You might just leak a few drops when you exercise, cough or sneeze (stress incontinence). Or you might leak larger amounts. Some men also leak urine when they get an erection or during sex.
Leaking urine usually improves with time. Most men start to see an improvement one to six months after surgery. But other men leak urine for a year or more, and some men never fully recover, even if they have treatments to help with their incontinence.
What can help with leaking urine?
Your treatment options will depend on how much urine you’re leaking, and how recently you had your prostate cancer treatment.
There are treatments and products available that can help:
absorbent pads and pants
pelvic floor muscle exercises
bed protectors and handheld urinals
If you have sudden urges to urinate (urinary urgency) and sometimes leak urine before you get to the toilet (urge incontinence), you may be offered bladder retraining.
If you still leak urine six to 12 months after surgery and pelvic floor muscle exercises haven’t helped, there are treatments available that might help. These may include:
Talk to your doctor or nurse about treatments and products that may be suitable for you.
Absorbent pads and pants
These can be worn inside your underwear, or instead of underwear. They soak up any leaks and are usually very discreet, so people won’t know you’re wearing them. Services vary from area to area, but your local NHS service may provide some pads for free. Talk to your doctor, nurse or continence advisor for more information.
Pelvic floor muscle exercises
These can strengthen the pelvic floor muscles, which help control when you urinate.
You might hear these called external catheters. These look like condoms with a tube attached to the end that drains urine into a bag. The sheath fits tightly over the penis and you can strap the bag to your leg – under your clothes – and empty it as needed.
Bed protectors and handheld urinals
Bed protectors are large pads that protect your sheets and mattress by soaking up any urine that you might leak. There are pads that you can wash and reuse, and others that you only use once before throwing them away
Handheld urinals are containers with a lid that can be used if you can’t reach the toilet in time or if there isn’t a toilet nearby. These might also be useful if you drive long distances and don’t have any toilet near you.
A penile clamp fits onto the penis and squeezes it, closing the urethra so that no urine can leak out. You should only use a penile clamp during the day for short periods of time, and should open it at least every two hours to let your blood flow back into your penis.
Penile clamps can be uncomfortable to wear and aren’t commonly used in the UK. They aren’t usually recommended by health professionals, as they reduce the blood flow to the penis. This means it can be unsafe if a clamp is put on too tightly or for too long.
This is a small piece of material that presses gently on your urethra to keep it closed and stop urine leaking. You’ll have an operation to fit the sling. It should be tight enough to stop urine leaking out, but loose enough to let you urinate when you want to.
You may be able to have an internal sling if you still leak a moderate amount of urine (if you use two to three pads a day) one year after your treatment for prostate cancer
The sling may not work as well if you leak a lot of urine or have previously had radiotherapy.
You’ll have an operation to fit the internal sling. You will usually have a general anaesthetic so you’ll be asleep.
Like all treatments, there can be side effects.
You may have some pain in the first three months after the operation.
You might get an infection – about one in 10 men (12 per cent) may need their sling removed because of an infection.
A small number of men have problems urinating (urine retention) after their operation, but this isn’t very common.
Your doctor or nurse can tell you more about the possible risks.
Artificial urinary sphincter
This involves surgery to fit a small device that consists of:
a fluid-filled cuff that fits around your urethra
a balloon in front of your bladder
a pump in your scrotum (the skin around your testicles).
The cuff presses the urethra closed so that you don't leak urine. This means you can control when you urinate.
You squeeze the pump in your scrotum – this moves the fluid out of the cuff and into the balloon.
When the cuff is empty it stops pressing your urethra closed, letting urine pass through the urethra so that you can urinate.
After a few minutes, the fluid flows back into the cuff, pressing the urethra closed again.
An artificial urinary sphincter is usually only suitable for men who still leak a lot of urine at least six months after their prostate cancer treatment.
You’ll have an operation to fit the device. You will have a general anaesthetic, so you’ll be asleep and won’t feel anything.
Like all operations, there are risks in having an artificial urinary sphincter, such as infection or parts of the device breaking. Some men need another operation to fix problems. Around one in 10 men (10 per cent) may need their device taken out. Your doctor or nurse can tell you more about the possible risks.
If your hospital doesn’t do this type of surgery, your doctor may be able to refer you to one that does.
This involves surgery to place two small fluid-filled balloons around your urethra (the tube you urinate through). The balloons press on the urethra to stop urine leaking out – but you should still be able to urinate when you want to.
Each balloon contains fluid and is attached to a device called a ‘port’, which is placed in your scrotum. Your doctor can use these ports to make the balloons bigger or smaller at any time. So if you still leak urine after the balloons are fitted, your doctor can inject more fluid into them so that they get bigger and press more on the urethra. If you can’t urinate properly, your doctor can remove some fluid from the balloons so they press on the urethra less.
Balloons may be an option if you still leak urine more than six months after your prostate cancer treatment. But you probably won't be able to have them if you've had radiotherapy.
There are risks in having these balloons. They include infection, or the balloons shrinking or moving, and you may need to have the balloons removed. Your doctor or nurse can tell you more about the possible risks.
Adjustable balloons aren’t very common in the UK. If your hospital doesn’t do this type of surgery, your doctor may be able to refer you to one that does.
If you continue to leak urine, or if other treatments aren’t suitable for you, you may be offered a medicine called an anti-cholinergic to help keep the urethra closed, or to calm your bladder down. This can help to reduce leakages. All drugs can cause side effects, so talk to your doctor or nurse about the possible side effects and how to manage them.
Some men may find it difficult to urinate after surgery (urine retention). This is caused by scarring, which can cause the urethra to become narrow. This isn’t very common after surgery.
Some men may leak urine after radiotherapy, but this is less common. It is more likely if you’ve previously had surgery for an enlarged prostate.
Radiotherapy can irritate the lining of the bladder and the urethra – this is called radiation cystitis. Symptoms include:
needing to urinate more often, including at night
a burning feeling when you urinate
blood in the urine.
Symptoms can start within a few days of your first treatment. They usually begin to improve when your treatment ends. But some men get symptoms for several months. And some don’t get symptoms until months or even years after their final treatment.
Symptoms such as blood in the urine can be worrying, but this is quite a common symptom of radiation cystitis.
If you get symptoms of radiation cystitis, tell your doctor or nurse. They can check whether your symptoms are caused by your treatment or an infection.
What can help with radiation cystitis?
There are treatments that can help with radiation cystitis, as well as things you can do yourself.
Drink plenty of fluids (1.5-2 litres, or 3-4 pints a day), but try to avoid fizzy drinks, drinks containing caffeine – such as tea, coffee and cola – and alcohol, as these can irritate the bladder.
Some men find that drinking cranberry juice helps. But you should avoid cranberry juice if you’re taking warfarin to thin your blood.
This is a liquid medicine that coats and protects the lining of the bladder, making it less irritated. A small tube (catheter) is passed up your penis and fills your bladder with the liquid medicine. You then go to the toilet to empty your bladder.
Urinary frequency and urgency
Some men find they need to urinate more often after having radiotherapy (urinary frequency). You may also need to urinate more often at night (nocturia). If this happens, it might help to drink less in the two hours before you go to bed.
You might get sudden urges to urinate that are hard to ignore (urinary urgency). And a small number of men leak urine before they can reach the toilet (urge incontinence). This happens when the bladder muscles twitch and squeeze (spasm) without you controlling them. This pushes urine out before you're ready.
What can help with urinary frequency and urgency?
There are treatments that can help with urinary frequency and urgency, as well as things you can do yourself.
If you need to urinate more often than usual or sometimes leak before reaching the toilet, you could try a technique called bladder retraining. This can help you control when you urinate, and help you hold on for longer. Speak to your specialist continence nurse or physiotherapist for more information.
Drugs called anti-cholinergics can help to reduce frequency, urgency and leaks. If you can't have anto-cholinergics, you may be offered mirabegron (Betmiga®) tablets.
This is quite a new treatment that may help some men to urinate and leak urine less often. A needle is placed under the skin just above your ankle. A low electrical current is passed through the needle to affect the nerves that control urination. This can help stop the bladder from emptying before it’s full.
Botulinum toxin (BOTOX®)
Injecting BOTOX® into the wall of the bladder can help stop the bladder squeezing out urine before it’s full. This is quite a new treatment for urinary frequency and urgency and it’s not available in all hospitals.
Some men find it hard to empty their bladder properly after radiotherapy – this is called urine retention. This may be more likely if you have an enlarged prostate. Radiotherapy, particularly brachytherapy, can cause the prostate to swell and block the urethra, leading to urine retention. It can also cause the urethra to become narrow – this is called a stricture.
Chronic urine retention
Some men can still urinate a little, but can’t empty their bladder fully – this is known as chronic urine retention. The first signs often include:
leaking urine at night
feeling that your abdomen (stomach area) is swollen
feeling that you’re not emptying your bladder fully
a weak flow when you urinate.
Tell your doctor or nurse if you get any of these symptoms. Chronic urine retention is usually painless, but the pressure of the urine can cause the bladder muscles to slowly stretch and become weaker. This can cause urine to be left behind in the bladder when you urinate. You may be more likely to get urine infections, bladder stones, blood in your urine or kidney problems.
Treatments for chronic urine retention include:
a catheter to drain urine from the bladder
drugs (alpha blockers or 5-alpha-reductase inhibitors)
surgery to widen the urethra or the opening of the bladder.
Acute urine retention
This is when you suddenly and painfully can’t urinate – it needs treating straight away. If this happens, call your doctor or nurse, or go to your nearest accident and emergency (A&E) department. They may need to use a catheter to drain your bladder.
Problems after high intensity focused ultrasound (HIFU)
You’re more likely to get urinary problems after HIFU if you’ve already had other treatments for prostate cancer. Possible urinary problems include:
HIFU usually causes the prostate to swell for a week or two, so you’ll have a catheter to drain urine from your bladder until the swelling has gone. HIFU can also cause the urethra to become narrow, making it difficult to empty your bladder (urine retention).
HIFU can cause some men to leak urine when they cough, sneeze or exercise (stress incontinence). This may be more likely if you’ve already had radiotherapy. There are ways to manage leaking urine.
Some men get a urine infection after HIFU. If this happens, you’ll be given a course of antibiotics to clear the infection.
You’re more likely to get urinary problems after cryotherapy if you’ve already had radiotherapy. Possible urinary problems include:
Cryotherapy can cause the prostate to swell, making it difficult to urinate for a week or two. You’ll have a catheter to drain urine from your bladder until the swelling has gone. Cryotherapy may also cause the urethra or the opening of the bladder to become narrow, making it difficult to urinate (urine retention).
A small number of men who have cryotherapy may leak urine. This is more likely if you’ve already had radiotherapy. There are ways to manage leaking urine.
How can I help myself?
Urinary problems can affect your self-esteem and independence, and affect your work, social and sex life.
Disability Rights UK runs a National Key Scheme for anyone who needs access to locked public toilets across the UK because of a disability or health condition.
If you often need to use the toilet at night, leave a light on in case you’re in a hurry, or keep a container near your bed.
Your GP, specialist nurse or continence nurse can offer you practical and emotional support. You can also speak to our Specialist Nurses. It can sometimes help to talk to other men living with prostate cancer. We have a range of services that can help put you in touch with someone who’s been there and understands what you’re going through. Visit our Who can help page to find out more.
Is the treatment I’m having for prostate cancer likely to cause any urinary problems?
What type of urinary problems might I get?
What should I do if I can’t urinate?
Will my urinary problems get better?
What treatments are available?
What are the risks and side effects of treatments for urinary problems?
What can I do to help myself?
Where can I get pads and other products?
Updated: May 2017 | Due for Review: May 2019
Full list of references used to produce this page
Abrams P, Shearer K. The MASTER trial: artificial urinary sphincter versus male sling. Trends Urol Mens Health. 2015;6(2):37–38.
Agarwal G, Spiess PE. Prostate cancer: Focal cryotherapy freezes recurrent disease in its tracks. Nat Rev Urol. 2013 Aug 27;10(10):562–3.
Alongi F, De Bari B, Campostrini F, Arcangeli S, Matei DV, Lopci E, et al. Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. Crit Rev Oncol Hematol. 2013 Dec;88(3):550–63.
American Medical Systems. AdVance XP Male Sling System: instructions for use. American Medical Systems, Inc.; 2012.
Anderson CA, Omar MI, Campbell SE, Hunter KF, Cody JD, Glazener CMA. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1:CD001843.
Arroyo Fernández R, García-Hermoso A, Solera-Martínez M, Martín Correa MT, Ferri Morales A, Martínez-Vizcaíno V. Improvement of Continence Rate with Pelvic Floor Muscle Training Post-Prostatectomy: A Meta-Analysis of Randomized Controlled Trials. Urol Int. 2014 Nov 22;94(2):125–32.
Aus G, Pileblad E, Hugosson J. Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. Eur Urol. 2002;42(2):133–138.
Bauer RM, Bastian PJ, Gozzi C, Stief CG. Postprostatectomy Incontinence: All About Diagnosis and Management. Eur Urol. 2009;55(2):322–33.
Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, et al. Contemporary Management of Postprostatectomy Incontinence. Eur Urol. 2011 Jun;59(6):985–96.
Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010;106(11):1734–8.
British Uro-oncology Group (BUG), British Association of Urological Surgeons (BAUS). Multi-disciplinary Team (MDT) Guidance for Managing Prostate Cancer. 2013.
Budäus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61(1):112–27.
Burkhard FC, Lucas MG, Berghmans LC, Bosch JLHR, Cruz F, Lemack GE, et al. EAU guidelines on urinary incontinence in adults [Internet]. European Association of Urology; 2016 [cited 2016 Jul 12]. Available from: http://www.academia.edu/download/33540169/20_Urinary_Incontinence_LR.pdf
Caso JR, Tsivian M, Mouraviev V, Kimura M, Polascik TJ. Complications and postoperative events after cryosurgery for prostate cancer. BJU Int. 2012;109(6):840–5.
Cordeiro ER, Cathelineau X, Thüroff S, Marberger M, Crouzet S, de la Rosette JJMCH. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int. 2012 Nov;110(9):1228–42.
Crivellaro S, Morlacco A, Bodo G, Agro’ EF, Gozzi C, Pistolesi D, et al. Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence: Systematic review of male SUI surgical treatment. Neurourol Urodyn. 2015 Sep;n/a-n/a.
de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013 Aug;112(3):298–307.
Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;
Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR. Incidence of Urethral Stricture After Primary Treatment for Prostate Cancer: Data From CaPSURE. J Urol. 2007 Aug;178(2):529–34.
Fischer MC, Huckabay C, Nitti VW. The Male Perineal Sling: Assessment and Prediction of Outcome. J Urol. 2007;177(4):1414–8.
Gacci M, Saleh O, Giannessi C, Chini T, Della Camera PA, Detti B, et al. Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study. Clin Genitourin Cancer. 2016 Feb 8;
Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13(1):1.
Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, et al. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials. Health Technol Assess. 2011;15(24).
Glover L, Gannon K, McLoughlin J, Emberton M. Men’s experiences of having lower urinary tract symptoms: factors relating to bother. BJU Int. 2004;94(4):563–7.
Grabe M, Bartoletti R, Bjerklund Johansen, Cai T, Cek M, Koves B, et al. Guidelines on Urological Infections [Internet]. European Association of Urology; 2015. Available from: http://uroweb.org/wp-content/uploads/18_Urological-infections_LR.pdf
Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, et al. Guidelines on non-neurogenic male lower urinary tract symptoms (LUTS) including benign prostatic obstruction [Internet]. European Association of Urology; 2016. Available from: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/
Habashy D, Losco G, Tse V, Collins R, Chan L. Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes. BJU Int. 2015 Oct;116:61–5.
Hamilton K, Bennett NC, Purdie G, Herst PM. Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study. Support Care Cancer. 2015 Jan;23(1):95–102.
Ishiyama H, Hirayama T, Jhaveri P, Satoh T, Paulino AC, Xu B, et al. Is There an Increase in Genitourinary Toxicity in Patients Treated With Transurethral Resection of the Prostate and Radiotherapy?: A Systematic Review. Am J Clin Oncol. 2014 Jun;37(3):297–304.
Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both. Eur Urol. 2015 Feb;67(2):273–80.
Jassim Y, Almallah Z. Incomplete emptying of the bladder and retention of urine. Trends Urol Gynaecol Sex Health. 2009;14(3):20–2.
Kidd EA, Stewart F, Kassis NC, Hom E, Omar MI. Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2015 [cited 2016 May 26]. Available from: http://doi.wiley.com/10.1002/14651858.CD004203.pub3
Kim SP, Sarmast Z, Daignault S, Faerber GJ, McGuire EJ, Latini JM. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol. 2008;179(5):1912–6.
Kolla SB, Dash A. Radiation Cystitis: Acute and Chronic. In: Ehrenpreis ED, Marsh R de W, Small W, editors. Radiation Therapy for Pelvic Malignancy and its Consequences [Internet]. New York, NY: Springer New York; 2015 [cited 2016 Jun 10]. p. 111–8. Available from: http://link.springer.com/10.1007/978-1-4939-2217-8_7
Kretschmer A, Hübner W, Sandhu JS, Bauer RM. Evaluation and Management of Postprostatectomy Incontinence: A Systematic Review of Current Literature. Eur Urol Focus [Internet]. 2016 Jan [cited 2016 Jul 20]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S2405456916000031
Levy D, Avallone A, Jones JS. Current state of urological cryosurgery: prostate and kidney. BJU Int. 2010;105(5):590–600.
Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, et al. High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review. Clin Oncol. 2011 Mar;23(2):117–27.
Macaulay M, Broadbridge J, Gage H, Williams P, Birch B, Moore KN, et al. A trial of devices for urinary incontinence after treatment for prostate cancer. BJU Int. 2015 Sep;116(3):432–42.
Marschall J, Carpenter CR, Fowler S, Trautner BW, for the CDC Prevention Epicenters Program. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ. 2013 Jun 11;346(jun11 1):f3147–f3147.
Moore D, Cohn J, Dmochowski R. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature. Toxins. 2016 Mar 23;8(4):88.
Moossdorff-Steinhauser HFA, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review. Neurourol Urodyn. 2013;32(3):206–14.
Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, et al. Guidelines on prostate cancer. European Association of Urology; 2016.
Mundy AR, Andrich DE. Posterior urethral complications of the treatment of prostate cancer. BJU Int. 2012;110(3):304–25.
National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: assessment and management. NICE Clinical Guideline 97. (modified June 2015); 2010.
National Institute for Health and Care Excellence. Mirabegron for treating symptoms of overactive bladder: Technical appraisal [Internet]. 2013. Available from: https://www.nice.org.uk/Guidance/ta290
National Institute for Health and Care Excellence. Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome. Interventional procedure guidance 362. 2010.
National Institute for Health and Care Excellence. Prostate Cancer: diagnosis and treatment. Full guideline 175. 2014.
National Institute for Health and Clinical Excellence. Cryotherapy for recurrent prostate cancer. Interventional procedure guidance 119. 2005.
Negro CL, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–1594.
Newman DK, Burgio KL, Markland AD, Goode PS. Urinary Incontinence: Nonsurgical Treatments. In: Griebling TL, editor. Geriatric Urology [Internet]. New York, NY: Springer New York; 2014 [cited 2016 Jun 13]. p. 141–68. Available from: http://link.springer.com/10.1007/978-1-4614-9047-0_11
Newman DK, Guzzo T, Lee D, Jayadevappa R. An evidence-based strategy for the conservative management of the male patient with incontinence: Curr Opin Urol. 2014 Nov;24(6):553–9.
Ohri N, Dicker AP, Showalter TN. Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol. 2012;19(4):6373.
Parihar JS, Ha Y-S, Kim IY. Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomy technique. Prostate Int. 2014 Mar;2(1):12–8.
Parsons BA, Evans S, Wright MP. Prostate cancer and urinary incontinence. Maturitas. 2009;63(4):323–8.
Payne H, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, et al. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013;
Pickard R, Bartoletti R, Bjerklund-Johansen TE, Bonkat G, Bruyere M, Çek M, et al. Guidelines on urological infections. European Association of Urology; 2016.
Rai BP, Cody JD, Alhasso A, Stewart L. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults (Review). Cochrane Database Syst Rev. 2012;(12).
Reynard J, Brewster S, Biers S. Oxford Handbook of Urology. 3rd ed. Oxford University Press; 2013.
Romano SV, Metrebian SE, Vaz F, Muller V, D’Ancona CA, Costa De Souza EA, et al. An adjustable male sling for treating urinary incontinence after prostatectomy: a phase III multicentre trial. BJU Int. 2006;97(3):533–9.
Shelley M, Wilt T, Coles B, Mason M. Cryotherapy for localised prostate cancer (Review). The Cochrane Collaboration, editor. Cochrane Database Syst Rev. 2007;(3).
Silva LA, Andriolo RB, Atallah ÁN, da Silva EM. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev. 2014;(9).
Smart C. Male urinary incontinence and the urinary sheath. Br J Nurs [Internet]. 2014 [cited 2016 Jul 13];23. Available from: http://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=09660461&AN=96014923&h=n3aaZT1G%2Brw57j2Qyvt80S%2FjC9XRHVa6%2BJ8sOk7DlYcPS8WnN3Ziy6UvWVby50HnL%2Bhndka25zsTpECBlv%2BM4Q%3D%3D&crl=c
Smit S, Heyns C. Management of radiation cystitis. Nat Rev Urol. 7:206–14.
Solomon CG, Schaeffer AJ, Nicolle LE. Urinary Tract Infections in Older Men. N Engl J Med. 2016 Feb 11;374(6):562–71.
Stewart F, Gameiro OL, El Dib R, Gameiro MO, Kapoor A, Amaro JL. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. The Cochrane Collaboration, editor. Cochrane Database Syst Rev [Internet]. 2016 Apr 2 [cited 2016 Jul 28]; Available from: http://doi.wiley.com/10.1002/14651858.CD010098.pub3
Thiruchelvam N, Cruz F, Kirby M, Tubaro A, Chapple CR, Sievert K-D. A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. BJU Int. 2015 Dec;116(6):853–61.
Thompson A, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, et al. Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis. J Clin Urol. 2014;7(1):25–35.
Uchida T, Nakano M, Hongo S, Shoji S, Nagata Y, Satoh T, et al. High-intensity focused ultrasound therapy for prostate cancer: HIFU and prostate cancer. Int J Urol. 2012 Mar;19(3):187–201.
Van Bruwaene S, De Ridder D, Van der Aa F. The use of sling vs sphincter in post-prostatectomy urinary incontinence: Sling vs AUS in PPUI. BJU Int. 2015 Sep;116(3):330–42.
Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults (Review). Cochrane Database Syst Rev. 2004;(1).
Welk BK, Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012;109(3):328–44.
Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148(6):435–448.
Yahya N, Ebert MA, Bulsara M, Haworth A, Kennedy A, Joseph DJ, et al. Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial. Radiother Oncol. 2015 Jul;116(1):112–8.
Yoon PD, Chalasani V, Woo HH. Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer Prostatic Dis. 2015 Dec;18(4):297–302.
Yutkin V, Ahmed HU, Donaldson I, McCartan N, Siddiqui K, Emberton M, et al. Salvage High-intensity Focused Ultrasound for Patients With Recurrent Prostate Cancer After Brachytherapy. Urology. 2014 Nov;84(5):1157–62.
Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol. 2008;70(4):1124–9.
Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. Conventional Treatments of Localized Prostate Cancer. Urology. 2008;72(6):S25–35.